Ameriprise’s Cardiol Therapeutics CRDL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDL
MI
Ameriprise's CRDL Position: Q3 2026 in Review
Ameriprise opened a new position in Cardiol Therapeutics (CRDL) in Q3 2026: 2,246,787 shares worth $3.73M. The stake represents ﹤0.01% of the portfolio and ranks #2728 among its holdings.
58 funds tracked by Wall St. Rank hold CRDL as of Q3 2026.
- Ameriprise held 2,246,787 shares of Cardiol Therapeutics worth $3.73M as of Q3 2026.
- Cardiol Therapeutics was a new Ameriprise position in Q3 2026.
- Cardiol Therapeutics made up ﹤0.01% of Ameriprise's portfolio in Q3 2026, its #2728 holding.
- 58 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q3 2026.
Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.